An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Pioneering genome sequencing study links rare genetic changes to congenital cardiac condition
New WGS study links rare genetic changes to Tetralogy of Fallot